Read + Share
Lipton RB, Harriott AM, Ma JY, Smith JH, et al. Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the
Migraine Prodrome: Results From the Randomized PRODROME Trial. Neurology 2024;103:e209745.
PMID: 39197113
|
 |
|
Lipton RB, Harriott AM, Ma JY, Smith JH, et al. Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the
Migraine Prodrome: Results From the Randomized PRODROME Trial. Neurology 2024;103:e209745.
PMID: 39197113
|
|
|
|